Suppr超能文献

FK506无法抑制小鼠对单核细胞增生李斯特菌的T细胞介导免疫。

Failure of FK 506 to suppress the T cell-mediated immunity of mice to Listeria monocytogenes.

作者信息

Wagner J A, Kretschmar M, Nichterlein T, Hof H, Quade B

机构信息

Institute of Medical Microbiology, Faculty for Clinical Medicine Mannheim, University of Heidelberg, Germany.

出版信息

Clin Exp Immunol. 1993 Jun;92(3):473-6. doi: 10.1111/j.1365-2249.1993.tb03423.x.

Abstract

Listeria monocytogenes belongs to the group of intracellular bacteria, which means that they reside and multiply within host cells. The protective immunity against such an infection is mediated by cellular immune mechanisms. Whereas the CD8+ T cell population plays a major role therein, the CD4+ T cells are held to be of minor importance in this defence system. Consequently, one can understand that immune suppression with FK 506 which acts primarily on this latter T cell subset, does not interfere with protective immunity of mice infected with L. monocytogenes. We have demonstrated that the drug blocks neither curing of primary infection, nor formation of granulomas, nor induction of cell populations capable of mediating adoptive transfer of immunity, nor expression of pre-existing immunity.

摘要

单核细胞增生李斯特菌属于细胞内细菌类别,这意味着它们在宿主细胞内生存和繁殖。针对这种感染的保护性免疫是由细胞免疫机制介导的。虽然CD8 + T细胞群体在其中起主要作用,但CD4 + T细胞在这个防御系统中被认为不太重要。因此,可以理解,主要作用于后一种T细胞亚群的FK 506免疫抑制不会干扰感染单核细胞增生李斯特菌的小鼠的保护性免疫。我们已经证明,该药物既不阻断原发性感染的治愈,也不阻断肉芽肿的形成,也不阻断能够介导免疫过继转移的细胞群体的诱导,也不阻断预先存在的免疫的表达。

相似文献

引用本文的文献

本文引用的文献

2
6
[Risk of infection during treatment with cyclosporin A].[环孢素A治疗期间的感染风险]
Dtsch Med Wochenschr. 1986 Nov 14;111(46):1770-5. doi: 10.1055/s-2008-1068710.
8
The oral dosage form of FK-506.FK-506的口服剂型。
Transplant Proc. 1987 Oct;19(5 Suppl 6):17-22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验